Previous 10 | Next 10 |
Our Danger Zone reports aim to identify firms that, despite more sanguine indications from traditional earnings[1] and noise traders , have struggling businesses and highly overvalued stock prices. These reports show investors how to use our research and display the transparency of our anal...
The past couple of weeks have been particularly hard on the cannabis sector. While many investors had hoped that revenue from Canada's 2.0 legalization would help out many companies, that hardly seems to be the case right now. Instead, it seems that the market is going to continue to be tumultuo...
The stage appeared to be set in 2019 for marijuana stocks to thrive, but this didn't prove to be the case. When the year ended, most cannabis stocks had logged big-time losses for the year, with Canadian pot stocks leading the way to the downside. A combination of supply concerns and a resilient...
The cannabis sector has been a source of heartache for investors over the past couple of years. After seeing the entire sector bubble up on high growth expectations, a number of factors have completely crushed the sector over much of the past year. A combination of slower-than-expected roll-ou...
Aurora Cannabis ( ACB ) dropped a number of negative news after the market closed last Thursday, further shaking investor confidence: CEO Terry Booth will step down and remain as a Board member. $1 billion impairment related to its international assets. Cut its workforce by 500 inclu...
Last year was a wake-up call for marijuana stock investors. For years, pot stocks had ascended to the heavens on promises of strong demand, rapid growth, and an expected quick push into the profit column. This vision looked especially feasible given Canada's legalization of recreational weed, su...
The magic mushroom boom is just beginning to sprout in the U.S. In recent months, Denver and Oakland decriminalized the possession of products containing psilocybin. Then, just last week, the Santa Cruz City Council voted to pass a resolution that decriminalizes psychedelic mushrooms. Howe...
MustGrow Biologics Corporation: (CSE: MGRO ) | (OTCQB: MGROF ) MustGrow is somewhat of a sleeper in the cannabis space as its one of those ancillary companies that have provided agricultural products for farmers of all kinds over the years. Their crop protection line is one that cannabis com...
If you're looking to invest in the cannabis market, now's definitely a tough time, with most large-cap pot stocks witnessing significant losses over the past 12 months. Coupled with the fact that the majority of them are still struggling to break even, it's not surprising why so many investors a...
At a dividend of 7.26%, massive write-downs and a decline in cigarette consumption are hardly bad news for Altria ( MO ). Risks are increasing on the possibility that the stock may retest the $40 low reached last year in September 2019. For the buy and hold investor, that is another chance t...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- FinancialBuzz.com News Commentary The breathalyzer market has experienced significant growth due to a heightened awareness of the dangers associated with impaired driving and the stringent enforcement of alcohol consumption laws globally. B...
Cronos Group Inc., (NASDAQ: CRON) a global cannabinoid company, has reported an increase in net revenue for the first quarter of 2024. The company&...
2024-05-09 13:30:17 ET Image source: The Motley Fool. Cronos Group (NASDAQ: CRON) Q1 2024 Earnings Call May 09, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Cronos Group (CRON) Q1 2024 Earnings Call Transcript